Clinical pharmacology in patients with evolving myocardial infarction of tissue-type plasminogen activator produced by recombinant DNA technology

A. J. Tiefenbrunn, A. K. Robinson, P. B. Kurnik, P. A. Ludbrook, B. E. Sobel

Research output: Contribution to journalArticle

62 Scopus citations

Fingerprint Dive into the research topics of 'Clinical pharmacology in patients with evolving myocardial infarction of tissue-type plasminogen activator produced by recombinant DNA technology'. Together they form a unique fingerprint.

Medicine & Life Sciences